Literature DB >> 22220819

Validity of a pediatric version of the Glasgow Outcome Scale-Extended.

Sue R Beers1, Stephen R Wisniewski, Pamela Garcia-Filion, Ye Tian, Thomas Hahner, Rachel P Berger, Michael J Bell, P David Adelson.   

Abstract

The Glasgow Outcome Scale (GOS) and its most recent revision, the GOS-Extended (GOS-E), provide the gold standard for measuring traumatic brain injury (TBI) outcome. The GOS-E exhibits validity when used with adults and some adolescents, but validity with younger children is not established. Because the GOS-E lacks the developmental specificity necessary to evaluate children, toddlers, and infants, we modified the original version to create the GOS-E Pediatric Revision (GOS-E Peds), a developmentally appropriate structured interview, to classify younger patients. The criterion, predictive, and discriminant validity of the GOS-E Peds was measured in 159 subjects following TBI (mild: 36%; moderate: 12%; severe: 50%) at 3 and 6 months after injury. Participants were included from two studies completed at the Pediatric Neurotrauma Center at Children's Hospital of Pittsburgh. We assessed the relationship among GOS-E Peds, the GOS, and the Vineland Adaptive Behavior Scales as well as other standardized measures of functional, behavioral, intellectual, and neuropsychological outcome. Premorbid function was assessed 24-36 h after injury. The GOS-E Peds showed a strong correlation with the GOS at 3 and 6 month time points. Criterion-related validity was also indicated by GOS-E Peds' association with most measures at both time points and at injury severity levels. The 3 month GOS-E Peds was associated with the 6 month GOS-E Peds, everyday function, behavior, and most cognitive abilities. Discriminant validity is suggested by weak correlations between both 3 and 6 month GOS-E Peds and premorbid measures. The GOS-E Peds is sensitive to severity of injury and is associated with changes in TBI sequelae over time. This pediatric revision provides a valid outcome measure in infants, toddlers, children, and adolescents through age 16. Findings support using the GOS-E Peds as the primary outcome variable in pediatric clinical trials.

Entities:  

Mesh:

Year:  2012        PMID: 22220819      PMCID: PMC3325553          DOI: 10.1089/neu.2011.2272

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  10 in total

1.  Traumatic brain injury in the United States: research and programs of the Centers for Disease Control and Prevention (CDC).

Authors:  Jean A Langlois; Richard W Sattin
Journal:  J Head Trauma Rehabil       Date:  2005 May-Jun       Impact factor: 2.710

2.  Validity and sensitivity to change of the extended Glasgow Outcome Scale in mild to moderate traumatic brain injury.

Authors:  H S Levin; C Boake; J Song; S Mccauley; C Contant; P Diaz-Marchan; S Brundage; H Goodman; K J Kotrla
Journal:  J Neurotrauma       Date:  2001-06       Impact factor: 5.269

Review 3.  Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale.

Authors:  G M Teasdale; L E Pettigrew; J T Wilson; G Murray; B Jennett
Journal:  J Neurotrauma       Date:  1998-08       Impact factor: 5.269

4.  Assessment of coma and impaired consciousness. A practical scale.

Authors:  G Teasdale; B Jennett
Journal:  Lancet       Date:  1974-07-13       Impact factor: 79.321

5.  Assessment of outcome after severe brain damage.

Authors:  B Jennett; M Bond
Journal:  Lancet       Date:  1975-03-01       Impact factor: 79.321

6.  Relationship of pediatric overall performance category and pediatric cerebral performance category scores at pediatric intensive care unit discharge with outcome measures collected at hospital discharge and 1- and 6-month follow-up assessments.

Authors:  D H Fiser; N Long; P K Roberson; G Hefley; K Zolten; M Brodie-Fowler
Journal:  Crit Care Med       Date:  2000-07       Impact factor: 7.598

7.  Assessing the outcome of pediatric intensive care.

Authors:  D H Fiser
Journal:  J Pediatr       Date:  1992-07       Impact factor: 4.406

8.  Predicting premorbid neuropsychological functioning following pediatric traumatic brain injury.

Authors:  K O Yeates; H G Taylor
Journal:  J Clin Exp Neuropsychol       Date:  1997-12       Impact factor: 2.475

9.  Outcome measures for clinical trials involving traumatically brain-injured patients: report of a conference.

Authors:  G L Clifton; R L Hayes; H S Levin; M E Michel; S C Choi
Journal:  Neurosurgery       Date:  1992-11       Impact factor: 4.654

10.  Disability after severe head injury: observations on the use of the Glasgow Outcome Scale.

Authors:  B Jennett; J Snoek; M R Bond; N Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-04       Impact factor: 10.154

  10 in total
  85 in total

1.  The Initiation of Rehabilitation Therapies and Observed Outcomes in Pediatric Traumatic Brain Injury.

Authors:  Karin Reuter-Rice; Julia K Eads; Suzanna Berndt; Karoline Doser
Journal:  Rehabil Nurs       Date:  2018 Nov/Dec       Impact factor: 1.625

2.  Connectome mapping with edge density imaging differentiates pediatric mild traumatic brain injury from typically developing controls: proof of concept.

Authors:  Cyrus A Raji; Maxwell B Wang; NhuNhu Nguyen; Julia P Owen; Eva M Palacios; Esther L Yuh; Pratik Mukherjee
Journal:  Pediatr Radiol       Date:  2020-06-30

3.  Recommendations for the use of common outcome measures in pediatric traumatic brain injury research.

Authors:  Stephen R McCauley; Elisabeth A Wilde; Vicki A Anderson; Gary Bedell; Sue R Beers; Thomas F Campbell; Sandra B Chapman; Linda Ewing-Cobbs; Joan P Gerring; Gerard A Gioia; Harvey S Levin; Linda J Michaud; Mary R Prasad; Bonnie R Swaine; Lyn S Turkstra; Shari L Wade; Keith O Yeates
Journal:  J Neurotrauma       Date:  2011-08-24       Impact factor: 5.269

4.  Comparison of equiosmolar dose of hyperosmolar agents in reducing intracranial pressure-a randomized control study in pediatric traumatic brain injury.

Authors:  S Arun Kumar; Bhagavatula Indira Devi; Madhusudan Reddy; Dhaval Shukla
Journal:  Childs Nerv Syst       Date:  2019-03-16       Impact factor: 1.475

5.  Functional Status Scale in Children With Traumatic Brain Injury: A Prospective Cohort Study.

Authors:  Tellen D Bennett; Rebecca R Dixon; Cory Kartchner; Peter E DeWitt; Yamila Sierra; Diane Ladell; Allison Kempe; Desmond K Runyan; J Michael Dean; Heather T Keenan
Journal:  Pediatr Crit Care Med       Date:  2016-12       Impact factor: 3.624

6.  Predictors of long-term neurological outcomes in non-accidental head injury.

Authors:  C F Chong; S L Misra; J A Escardo-Paton; S Dai
Journal:  Eye (Lond)       Date:  2017-12-08       Impact factor: 3.775

7.  Self- and parent-reported Quality of Life 7 years after severe childhood traumatic brain injury in the Traumatisme Grave de l'Enfant cohort: associations with objective and subjective factors and outcomes.

Authors:  Hugo Câmara-Costa; Marion Opatowski; Leila Francillette; Hanna Toure; Dominique Brugel; Anne Laurent-Vannier; Philippe Meyer; Laurence Watier; Georges Dellatolas; Mathilde Chevignard
Journal:  Qual Life Res       Date:  2019-09-23       Impact factor: 4.147

8.  Phenotyping in Pediatric Traumatic Brain Injury.

Authors:  Michael A Carlisle; Tellen D Bennett
Journal:  Pediatr Crit Care Med       Date:  2018-10       Impact factor: 3.624

9.  Treatment Practices and Outcomes After Blunt Cerebrovascular Injury in Children.

Authors:  Michael C Dewan; Vijay M Ravindra; Stephen Gannon; Colin T Prather; George L Yang; Lori C Jordan; David Limbrick; Andrew Jea; Jay Riva-Cambrin; Robert P Naftel
Journal:  Neurosurgery       Date:  2016-12       Impact factor: 4.654

10.  Multimodal Assessment of Cerebral Autoregulation and Autonomic Function After Pediatric Cerebral Arteriovenous Malformation Rupture.

Authors:  Brian Appavu; Stephen Foldes; Brian T Burrows; Austin Jacobson; Todd Abruzzo; Varina Boerwinkle; Anthony Willyerd; Tara Mangum; Vishal Gunnala; Iris Marku; P D Adelson
Journal:  Neurocrit Care       Date:  2020-08-04       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.